• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 437375 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413979549 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413979549 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Illumina Shares Climbing Higher, Up 1.4%

Published on Wed, 02/06/2013 - 11:26
By Robert Cotter

Up 1.4% to $51.70, Illumina (NASDAQ:ILMN), is one of today's notable movers. The S&P is currently trading fractionally lower to 1,509 and the Dow Jones Industrial Average is trading 0.2% lower to 13,945.

In the past 52 weeks, shares of Illumina have traded between a low of $25.57 and a high of $79.40 and are now at $51.70, which is 102% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has remained constant.

There is potential upside of 6.1% for shares of Illumina based on a current price of $51.70 and an average consensus analyst price target of $54.88. The stock should find resistance at its 50-day moving average (MA) of $52.52, as well as support at its 200-day MA of $46.39.

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Short-term Underperformance Detected in ...

Here are 5 stocks in the Multi-Utilities industry ranked by performance. We compiled t ...

Best Relative Performance in the Health ...

Here are the top 5 stocks in the Health Care Facilities industry ranked by performance. ...

Shares of Redwood Trust Underperformed i...

Below are five companies in the Mortgage REITs industry that underperformed yesterday o ...

DexCom is Among the Companies in the Hea...

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. ...

International Business Machines had the ...

Analysis was conducted on the IT Consulting & Other Services industry to measure relati ...

Owens & Minor is Among the Companies in ...

We looked at the Health Care Distributors industry and measured relative performance to ...

Analysis of Relative Performance in the ...

Below are five companies in the Internet Software & Services industry that underperform ...

Wolverine World Wide has the Best Relati...

Here are the top 5 stocks in the Footwear industry ranked by performance. We compiled ...